News

In The News Lindsay Bealor Greenleaf, VP of Policy at ADVI, recently shared her thoughts with Bloomberg Law about the impacts of an appeals court decision to uphold reimbursement cuts for hospitals receiving drugs under the 340B discount program
In The News ADVI Director, Becca Davison, sat down with Modern Healthcare to discuss the lack of transparency surrounding 340B and how manufacturers are engaging with entities utilizing the program
In The News ADVI’s Vice President, Dr. Michael Kolodziej, talked to The American Journal of Managed Care about the side effects of first-gen BTK inhibitors
In The News ADVI’s Lindsay Bealor Greenleaf sat down with CNBC to share her thoughts on the White House’s recent executive orders on drug pricing reform, and how the proposal could have unintended consequences leading to increased Medicare spending
In The News ADVI Health CEO, Marc Samuels, spoke with AIS Health about the Trump administration’s drug pricing executive orders, and why they might face industry backlash
In The News ADVI’s Vice President, Lindsay Bealor Greenleaf, explained to Modern Healthcare about the implications of CMS’ new proposed rule for Medicaid
In The News ADVI Vice President, Dr. Michael Kolodziej, recently shared his thoughts on how commercial insurers and hospitals are being impacted by the Covid-19 pandemic with The Cancer Letter
In The News ADVI’s Director, Becca Davison, connected with Fox Business to discuss what she’d like to see from lawmakers when it comes to health policy
In The News ADVI’s Lindsay Bealor Greenleaf talks to Politico about the new Medicaid proposed rule